Head to Head Comparison: Black Titan (BTTC) & Its Peers

Black Titan (NASDAQ:BTTC) is one of 48 publicly-traded companies in the “Services – Computer Programming And Data Processing” industry, but how does it weigh in compared to its peers? We will compare Black Titan to related companies based on the strength of its risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Earnings & Valuation

This table compares Black Titan and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Black Titan	$180,000.00	-$4.71 million	-0.58
Black Titan Competitors	$233.35 million	-$56.06 million	-11.25

Black Titan’s peers have higher revenue, but lower earnings than Black Titan. Black Titan is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Volatility and Risk

Black Titan has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, Black Titan’s peers have a beta of 0.54, suggesting that their average stock price is 46% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Black Titan and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Black Titan	1	0	0	0	1.00
Black Titan Competitors	96	199	216	12	2.28

As a group, “Services – Computer Programming And Data Processing” companies have a potential upside of 137.60%. Given Black Titan’s peers stronger consensus rating and higher probable upside, analysts plainly believe Black Titan has less favorable growth aspects than its peers.

Profitability

This table compares Black Titan and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Black Titan	N/A	-108.60%	-95.64%
Black Titan Competitors	-37.79%	-997.78%	-64.21%

Insider & Institutional Ownership

57.9% of shares of all “Services – Computer Programming And Data Processing” companies are held by institutional investors. 53.7% of Black Titan shares are held by insiders. Comparatively, 20.6% of shares of all “Services – Computer Programming And Data Processing” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Black Titan peers beat Black Titan on 7 of the 12 factors compared.

About Black Titan

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.